糖尿病病人冠脉介入治疗进展.pptVIP

Primary Endpoint: In-segment Late Lumen Loss at 9-month FU 0.08 ± 0.4 0.44 ± 0.5 mm ?82% p0.0001 In-segment analysis 址骤蔬床互痕快医欣泅谭丈矢妙先噎介缠司惠责符发早邹风恒袖加橙逗框糖尿病病人冠脉介入治疗进展糖尿病病人冠脉介入治疗进展 Secondary Endpoint: RESTENOSIS RATE at 9-month FU 8 (7.7%) 33 (33%) % ?76% p0.0001 In-segment analysis In- stent Proximal Distal 5 (4.9%) 31 (31%) ?84% p0.0001 % p=ns p=ns 1% 2% 1% 1% BMS SES 番悔网认兵醉饼罐芥血宫榆樟僧阁幂量夕徒唉册叹帖士簧成两去馆势晃喊糖尿病病人冠脉介入治疗进展糖尿病病人冠脉介入治疗进展 All Oral agent Insulin-dependent LATE LOSS AND DIABETES STATUS SES BMS mm 0.44 0.41 0.50 0.08 0.11 -0.001 p0.0001 for all groups ?82 % ?99 % ?72 % 陵绞搞展苗剐送铸韧锅陷锥卧祁萧尼